High-Dose Semaglutide: Balancing Marginal Glycemic Benefits With Tolerability Trade-Offs " El uso de dosis altas de SEMA (ms all de 2 mg/semanal) aporta solo mejoras glucmicas modestas (reduccin adicional de HbA1c de 0,3-0,5%), pero aumenta de forma significativa la prdida de peso (3,4-4,5 kg adicionales) en comparacin con dosis menores
Science 339 , 13201323 (2013)
Mechanisms of action and therapeutic applications of GLP1 and dual GIP/GLP1 receptor agonists
Most people rely on scattered notes that bury patterns, so try MeAgain, which centralizes injections, protein, fiber, hydration, and symptom logs into one place
Nothing on this page is a recommendation to use these compounds in humans outside a licensed clinical or research context